Fagron’s strategy is focused on optimizing and innovating customized pharmaceutical care in order to widen the therapeutic options of prescribers worldwide. As the leading global company in pharmaceutical compounding, we are supporting the unique selling point of customized medication and improving patients’ quality of life.
As the leading company in pharmaceutical compounding, Fagron develops innovative concepts and solutions that respond to the specific and individual wishes of compounding pharmacies all over the world. In Fagron’s Innovation department, over 200 pharmacists are dedicated to developing and providing innovative concepts, products and formulas that will meet the demands of the pharmacist, prescriber and patient.

Type
Public
HQ
Rotterdam, NL
Founded
1990
Size (employees)
2,334 (est)
Website
fagron.com
Fagron was founded in 1990 and is headquartered in Rotterdam, NL
Report incorrect company information

Key People/Management at Fagron

Rafael Padilla

Rafael Padilla

Chief Executive Officer
Karin de Jong

Karin de Jong

Chief Financial Officer
Constantijn van Rietschoten

Constantijn van Rietschoten

Chief Communications Officer
Rita Hoke

Rita Hoke

President of Fagron North America

Fagron Office Locations

Fagron has an office in Rotterdam
Rotterdam, NL (HQ)
182 Lichtenauerlaan
Show all (1)
Report incorrect company information

Fagron Financials and Metrics

Fagron Financials

Market capitalization (3-Mar-2017)

830.5 b

Closing share price (3-Mar-2017)

11.7
Fagron's current market capitalization is €830.5 b.
Show all financial metrics
Report incorrect company information

Fagron News and Updates

Compounding Pharmacies Market share valued $12bn by 2024

Compounding pharmacies market players include Fresenius Kabi, B. Braun Medical, Fagron, PharMEDium, Cantrell Drug Company, ITC Compounding Pharmacy, Village Compounding Pharmacy, and Wedgewood Village Pharmacy. Companies are consolidating their market position through adoption of strategies such as …

Compounding Pharmacy Market 2017 Global Analysis By key Players – Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, PharMEDium Services

WiseGuyReports.Com Publish a New Market Research Report On - “Compounding Pharmacy Market 2017 Global Analysis By key Players – Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, PharMEDium Services”. Posted via Industry Today. Follow us on Twitter @IndustryToday

Compounding Pharmacy Global Market 2017: Key Players – Fagron, Wedgewood Pharma, CAPS, Fresenius Kabi, PharMEDium Services

Compounding Pharmacy -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022 Posted via Industry Today. Follow us on Twitter @IndustryToday

Compounding Pharmacies Market Size to Accelerate US$ 9.7 Bn by 2021

According to the latest market report published by Persistence Market Research titled ‘Global Market Study on Compounding Pharmacies: Asia Pacific is expected to witness highest growth by 2021’, Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information